PATENT CLAIM ANALYSIS

Application Number: 15901063
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "282000"]

Abstract:
A thermoformed pharmaceutical dosage form having a breaking strength of at least 300 N, said dosage form comprising a pharmacologically active ingredient (A), a free physiologically acceptable acid (B) in an amount of from 0.001 wt.-% to 5.0 wt.-%, based on the total weight of the pharmaceutical dosage form, and a polyalkylene oxide (C) having a weight average molecular weight M w  of at least 200,000 g/mol.

Claim (Index 14):
A process for the production of the pharmaceutical dosage form according to  claim 1  comprising the steps:\n a) mixing all components to form a resultant mixture; \n b) heating the resultant mixture in an extruder at least up to the softening point of the polyalkylene oxide (C) and extruding extrudate through the outlet orifice of the extruder by application of force, \n c) singulating the still plastic extrudate and forming into the pharmaceutical dosage form or \n d) cooling and optionally reheating the singulated extrudate and forming it into the pharmaceutical dosage form.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 88.0
- Lexical Diversity: 1.53846
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14841829', '13223384', '14979888', '14287512', '14719351']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.745259544843338
- 35 USC 102 Novelty (BERT): 0.5320141051225584
- Combined Prediction Score: 0.7239350008712601
- Mean Citation Score: 294.533644
- Max Citation Score: 369.1244
- Similarity Product: 356.15339873137464

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test